eHealth reports Q2 revenue down 45% to $33.6M amid strategic shift to member engagement

The company announced its financial results for the second quarter and first half of 2026. The press release is furnished as Exhibit 99.1 but the specific financial metrics are not disclosed in the body of this 8-K.

The company posted additional investor materials on its website and confirmed it will use this channel for material disclosures under Regulation FD. This establishes the investor relations webpage as an official disclosure channel alongside traditional SEC filings.

eHealth reported Q2 2026 total revenue of $33.6 million, down 45% from $60.8 million in Q2 2025. GAAP net loss widened to $23.6 million from $17.4 million. Operating cash flow improved significantly to negative $5.0 million from negative $41.2 million, a $36.2 million improvement driven by disciplined expense management and cost reduction initiatives.

The company launched a lifetime advisory model aimed at increasing member engagement and retention. Early results show ancillary product cross-sell rates doubled year-over-year, indicating improved member engagement. This strategic shift focuses on existing member relationships rather than new acquisition volume.

Operating costs declined 27% to $61.0 million from $83.8 million, driven by a cost reduction program implemented in January 2026. The company expects to achieve over $60 million in annual variable spend reductions and approximately $30 million in annual fixed cost savings versus the prior year.

Total revenue fell 45% year-over-year to $33.6 million in Q2 2026, driven by lower Medicare enrollment volume. The company states this decline was intentional, reflecting a strategic shift to reduce variable marketing spend outside major enrollment periods and focus on existing member engagement. GAAP net loss widened to $23.6 million from $17.4 million a year ago, and adjusted EBITDA declined to negative $21.8 million from negative $14.1 million. However, operating cash flow improved substantially to negative $5.0 million from negative $41.2 million a year ago.

eHealth launched a new Lifetime Advisory model in April 2026 aimed at deepening member-advisor relationships and driving engagement, retention, and lifetime value. Early results show ancillary product cross-sell rates doubled year-over-year in Q2 2026, and the company observed improvements in key member engagement metrics including higher email capture rates, higher email open and response rates, and increased member requests to speak with dedicated benefit advisors. The company states this operating model change intentionally drove lower volume and revenue in the near term, with impact expected to be especially pronounced in Q2 and Q3 2026.

eHealth implemented a cost reduction program in January 2026 that is showing early impact. Total operating costs and expenses declined 27% year-over-year in Q2 2026, with combined technology and content and general and administrative expenses declining 18%. The company states it is on track to achieve more than $60.0 million in annual variable spend reductions and approximately $30.0 million in annual fixed cost savings compared to the prior year.

The company reported commissions receivable of $1.0 billion as of June 30, 2026, representing 10% year-over-year growth from $917 million at June 30, 2025. The company states this balance is supported by conservative lifetime value assumptions and consistent positive net adjustment revenue. Cash, cash equivalents and marketable securities totaled $101.0 million.

eHealth updated its 2026 full-year guidance for positive net adjustment revenue (tail revenue) to a range of $16 million to $20 million, up from the previous range of $8 to $20 million, reflecting Q2 2026 positive net adjustment revenue of $7.6 million. The company maintained its full-year guidance ranges: total revenue of $405 million to $445 million, GAAP net income of $8 million to $25 million, adjusted EBITDA of $55 million to $75 million, and operating cash flow of negative $10 million to positive $12 million.